Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1993-02-10
1994-05-10
Nucker, Christine M.
Drug, bio-affecting and body treating compositions
Lymphokine
53038822, 53038873, 5303896, A61K 3900, A61K 39395, C07K 1528
Patent
active
053105516
ABSTRACT:
A method for inhibiting pulmonary oxygen toxicity in a patient requiring elevated levels of inhaled oxygen, by prophylactic administration of certain adhesion molecules and antibodies thereto.
REFERENCES:
patent: 5109123 (1992-04-01), Reinherz et al.
Barton et al., J. Immunol. 143:1278-1282 (1989) "The effect of anti-intercellular adhesion molecule-1 on phorbol-ester-induced rabbit lung inflammation".
Gallin, J. I. in Fundamental Immunology (W. F. Paul, (ed)) Ch. 26, pp. 721-733 (1989), "Inflammation".
Ruoslahti, et al. in Syn. Peptides in Biology and Medicine, pp. 191-197 (1985) "Synthetic peptides in analysis of cell adhesion".
Shevach, et al. in Fundamental Immunology (W. F. Paul (ed.)) Ch. 15, pp. 413-422, 437-438 (1989) "Accessory molecules".
Wegner et al., Science 247:456-459 (Jan. 20, 1990), "Intercellular adhesion molecule-1 (1 ICAM-1) in the pathogenesis of asthma".
Letts L. Gordon
Wegner Craig D.
Boehringer Ingelheim Pharmaceuticals Inc.
Cunningham Thomas
Nucker Christine M.
LandOfFree
Method for inhibiting pulmonary oxygen toxicity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for inhibiting pulmonary oxygen toxicity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for inhibiting pulmonary oxygen toxicity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2411554